4163 Stock Overview
Primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Al-Dawaa Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س90.20 |
| 52 Week High | ر.س121.60 |
| 52 Week Low | ر.س84.80 |
| Beta | -0.0043 |
| 11 Month Change | 4.88% |
| 3 Month Change | -1.53% |
| 1 Year Change | -12.93% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 14.76% |
Recent News & Updates
Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03
Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns
Apr 05Recent updates
Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns
Apr 05Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger
Dec 26Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25
Sep 03Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing
Jul 13Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 22Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)
Apr 10Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio
Mar 14Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?
Dec 08Shareholder Returns
| 4163 | SA Consumer Retailing | SA Market | |
|---|---|---|---|
| 7D | 0.8% | -0.7% | -1.5% |
| 1Y | -12.9% | -14.0% | -8.8% |
Return vs Industry: 4163 matched the SA Consumer Retailing industry which returned -13.9% over the past year.
Return vs Market: 4163 underperformed the SA Market which returned -8.9% over the past year.
Price Volatility
| 4163 volatility | |
|---|---|
| 4163 Average Weekly Movement | 3.5% |
| Consumer Retailing Industry Average Movement | 4.1% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in SA Market | 7.3% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 4163 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4163's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Mohammed Saad Al-Farraj Al-Subaie | www.al-dawaa.com.sa |
Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products.
Al-Dawaa Medical Services Company Fundamentals Summary
| 4163 fundamental statistics | |
|---|---|
| Market cap | ر.س7.66b |
| Earnings (TTM) | ر.س348.30m |
| Revenue (TTM) | ر.س5.85b |
22.0x
P/E Ratio1.3x
P/S RatioIs 4163 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4163 income statement (TTM) | |
|---|---|
| Revenue | ر.س5.85b |
| Cost of Revenue | ر.س3.76b |
| Gross Profit | ر.س2.09b |
| Other Expenses | ر.س1.75b |
| Earnings | ر.س348.30m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.10 |
| Gross Margin | 35.80% |
| Net Profit Margin | 5.95% |
| Debt/Equity Ratio | 53.8% |
How did 4163 perform over the long term?
See historical performance and comparison